Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 397 record(s)

Req # A-2020-04135

Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

79 page(s)
September 2020

Req # A-2020-09098

Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
September 2020

Nothing to report this month

Organization: Business Development Bank of Canada

September 2020

Req # ATI2021-009

Briefing notes, financial reports, memos, and other reports that discuss or are related to the Business Credit Availability Program (BCAP) for the month of February, March, April, May, June 2020.

Organization: Business Development Bank of Canada

27 page(s)
August 2020

Req # A-2020-01436

Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

20 page(s)
August 2020

Req # A-2020-04137

Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

17 page(s)
August 2020

Nothing to report this month

Organization: Business Development Bank of Canada

July 2020

Req # ATI2021-003

Provide any and all records regarding an article in the Logic: EDC trial program to match up to $5 million in investments to help small businesses hit by COVID-19 (April 7, 2020)

Organization: Business Development Bank of Canada

89 page(s)
June 2020

Req # ATI2021-004

Provide any and all records regarding an article in the Logic: Ottawa in talks with fintechs on $2-billion plan to lend money to an additional 100,000 firms (April 16, 2020)

Organization: Business Development Bank of Canada

182 page(s)
June 2020

Req # ATI2021-005

Provide any and all records regarding an article in the Logic: Investors worry Canada’s most promising startups will be left out of BDC’s emergency fund-matching program (April 23, 2020)

Organization: Business Development Bank of Canada

317 page(s)
June 2020
Date modified: